chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I received the first dose of Moderna in March 2021. After that shot, I had difficulty walking for two weeks. When I tried to move forward, the center of my back and my sides felt very strained as if I was pulling a bus behind me. The symptoms completely went away after those two weeks. I decided not to get the second vaccine. However, around August 20, 2021, it was mandated the vaccine for teachers. My doctor refused to give me an exemption, so in order to save my carreer, I got the second dose. That was 17 weeks ago, and I have been unable to work since then. Within a day or two of the second vaccine, I had a much more severe reaction.  The vaccine devastated my nervos system.  It was 3 months before I could begin to walk beyond 20-30 steps. Something was wrong deep inside my spinal cord. It wasn't an injury because I could stretch without any muscle pain. During that time, I had concussion-like symptoms that kept me sitting in a dark room with sunglasses on.  I could not handle any screentime or flashing lights of any kind. I could not ride in a car because the movement and stimulation was intolerable. My eyes couldn't focus from one thing to another. I had continuous mild eye headaches. When I tried to walk, I had intense pressue on the back of my head and neck. It was terrible strain on my spinal cord to walk. After a handful of slow steps, I felt as if my brain wouldn't communicate with my legs to tell them to move forward. I was unable to strain my body in any way. I could not cut vegetables, couldn't carry objects without cradling them to my chest. I could not push/pull a vaccuum cleaner. I was extremely sick and weak for those first 3 months. I was unable to work, to drive, to exercise, or to take care of my household. After exerting myself or using my eyes, I had to sleep in order to relieve the discomfort and ease the cognitive stress that I felt from using my eyes. In the fourth month, my symptoms began to subside. I have slowly increased the distance that I can walk and the light sensitivity has eased. I am just beginning to handle the stimulation of being in a car and in public places. I can drive short distances, but my eyes are very strained. I am a fourt grade teacher and I have not even met my class this year.    09/03/2021 - all tests came back normal  Complete Blood Count, with Differential -     Comprehensive Metabolic Panel; Future -     TSH Reflex Free T4; Future -     Comprehensive Metabolic Panel -     TSH Reflex Free T4 -     Ganglioside Gm-1 Antibody, IgG, IgM  09/23/2021 - Brain MRI with Contrast - results were normal  10/01/2021 - Emergency Room Visit Blood Tests - all came back negative or in normal ranges Miscellaneious Test, ARUP Sedimentation Rate C3 Complement C$ Complement C-Reative Protein JO-1 Antibody Aldolase, Seru ANA, IGG by ELISA w REflex to HEP-2 Lyme Disease Giemsa Stain   10/19/2021 - Neurological exam with Dr. - results were normal; adverse neurological effects from vaccine should diminish over time I was given a 5-day steroid pack. It did not have any affect on me other than sleeplessness.  11/1/2021 - Dr., Rheumatologist - All tests came back normal;  I do not have an autoimmune disease
Patient ordered to receive Dtap, Hep B, IPV combination vaccine. Dtap (INFANRIX) administered instead of combination vaccine (PEDIARIX). Age of patient at time of event: 2 months.
Received the COVID vaccine, after the 30 min observation time she left the area and returned about an hour after her administration with complains of Shortness of breath, tightness in chest, elevated BP, Flushing and rash on upper extremities and neck.
Pain; Hives; Left arm was sore at the injection site; Headache; Developed a bruise; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced injection site pain, headache, contusion, pain and hives. On an unknown date, the outcome of the injection site pain, headache, pain and hives were recovered/resolved and the outcome of the contusion was not recovered/not resolved.  It was unknown if the reporter considered the injection site pain, headache, contusion, pain and hives to be related to Shingrix.  Additional details provided were as follows: Age at vaccination was not reported. The patient reported that, she received a dose of the shingrix vaccine and she developed a headache, her left arm was sore at the injection site, she developed a bruise, pain, and hives, which were resolved with Benadryl. Her headache was resolved, the hives had resolved and the arm pain has resolved. The bruise was the only symptom that had not resolved. Patient was advised to speak to health care professional. No other information was reported. The reporter did not consented to follow-up.
Headaches started on 1/21/2021, then loss of vision left eye on 3/4/2021, on 3/14/2021-lost vision in right eye
Vaccine administered into bursa. Pt has had recurring pain and received a cortisone injection. Pain resolved, but in pain again now. Hurts to lift arm.
Incorrect vaccine given to patient. Patient received 6 month to 5 years age group primary dose vaccine. However, this patient should have received 6-11 year old primary dose of covid Moderna vaccine. No adverse reaction or symptoms following vaccine administration.
2/9/21 0800 Pt called regarding delayed rxn to vaccine moderna. Pt rcv'd moderna 2nd dose on 2/5/21 and developed sx's 2/6/21 around 1700-1800. Pt contacted PCP. PCP stated it was a delayed rxn to vaccine. PCP informed pt to tx with tylenol, ibuprofen, benadryl and cold compress. PCP also informed pt to go to ED for anaphylaxis sx's.  Pt reports hx of rxn to previous vaccination. Pt stated 1st vaccination of moderna was not severe. Pt sx's verbally reported following 2nd moderna dose:  -swollen lymph nodes in neck and axillary region -streaking on arm of injection -rash on arm of injection -fevers 101-102 -chills -diarrhea -H/A -Muscle pain -ear pain and swelling
Raised Hives all over the body.  Gave  Benadryl 25mg tablet at 6:45 pm at home.  Hives kept spreading so took him to the Urgent care at 7:45 pm on Tuesday, August 2, 2022.  They gave him Diphenhydramine50mg,  Methylprednisolone 125mg,  and Famotidine 20mg in normal saline water 1 liter through IV.   He was also given Methylprednisolone 20mg tablets to take for a week, starting with 60mg for the first two days, then 20mg for three days and 10 mg for three days along with Benadryl 25mg tablets and antihistamine tablet twice daily until the hives subsided.  The next day he was taken to the ER and was given the same medicines through IV.
Patient received ZOSTAVAX on Monday 4/4/16. She called the pharmacy on Thursday 4/1/16 to say she thinks she is having a reaction to the vaccine. She said it is a large red spot that is slightly painful. It did not appear until Wed night. She was told to ice it, try some BENADRYL and call her doctor. She said the size of the spot hasn't changed from Wed to Thurs.
Pt has a history of diabetes and arrives at the hospital due to hypoxemia, generalized weakness, and a cough.  He is admitted due to acute hypoxic respiratory failure secondary to COVID-19 pneumonia.
Since 2021-2023 I have had a peanut allergy after having Pfizer vaccines. It goes away but my throat feels sensitive/irritated/pressured and I cough and then it goes away.
Around 3 hours after the vaccine I started having sinus pressure, running nose, coughing and sneezing, chills, 102 f fever
Information has been received from a doctor of pharmacy student concerning a 69 year old female with no history of drug reactions or allergies who on 28-JAN-2008 was vaccinated subcutaneously into the right arm with ZOSTAVAX (Oka/Merck) (Lot #658862/1415U). On 29-JAN-2008 the patient developed a rash "on the right side only and only on her bottom". The patient was treated with acyclovir. The patient's rash hs stayed "about the same" since it started and remained present at the time of reporting. It is unknown if medical attention was sought. There was no product quality complaint. Additional information has been requested.
Dizzyness immediately after receiving shot, fatigue all day, sore arm for 2 days
Patient had redness, swelling, pain and warmth below where the vaccine is typically given. Patient to the doctor and was given antibiotics.
Vaccination failure; COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 71-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 04Oct2022 as dose 5 (booster), single (Lot number: GJ5342), in left arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 27May2022 as dose 4 (booster), single (Lot number: FJ4991), in left arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 03Feb2021 as dose 1, single (Lot number: EM9809), in left arm, on 25Feb2021 as dose 2, single (Lot number: EN6203), in left arm and on 29Sep2021 as dose 3 (booster), single (Lot number: 30155BA), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Endometriosis" (unspecified if ongoing); "Graves Disease" (unspecified if ongoing), notes: (treated); "known allergies: Sulfa drugs" (unspecified if ongoing); "known allergies: Peanuts" (unspecified if ongoing). Concomitant medication(s) included: LEVOTHYROXINE, start date: Dec2008. The following information was reported: COVID-19 (medically significant) with onset Jan2023, outcome "unknown"; VACCINATION FAILURE (medically significant) with onset Jan2023, outcome "unknown". Therapeutic measures were taken as a result of vaccination failure, covid-19 included Paxlovid.
Presented to ED on 3/10/21 for migraine and discharged home. Reported only sore arm following vaccination. Presented to ED on 3/7/21 with back pain, no COVID symptoms reported and was discharged home.  Presented to ED on 3/10/21 with generalized body aches, nausea, vomiting, and headache for 2 days. Noted mild cough and sinus congestion and was admitted to hospital for 5 days until 3/14/21.  Returned to ED on 3/15/21 with worsening shortness of breath and was admitted to hospital for another 5 days until 3/19/21.
J96.21 ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 5/23/2021 UNSPECIFIED ANXIETY DISORDER J96.22 ACUTE ON CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 5/23/2021 UNSPECIFIED ANXIETY DISORDER J96.21 ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 5/23/2021 NONTRAUMATIC ACUTE KIDNEY INJURY J96.22 ACUTE ON CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 5/23/2021 NONTRAUMATIC ACUTE KIDNEY INJURY J96.21 ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 5/23/2021 WEAKNESS J96.22 ACUTE ON CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 5/23/2021 WEAKNESS J96.21 ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 5/23/2021 ACUTE ON CHRONIC HYPERCAPNIC RESPIRATORY FAILURE J96.22 ACUTE ON CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 5/23/2021 ACUTE ON CHRONIC HYPERCAPNIC RESPIRATORY FAILURE
On 12/13/22, 12 Pfizer Bivalent boosters were administered at two shelters.  The two loose unpunctured vials had expiration dates of 12/09/22.  The vaccine had expired 4 days earlier, expirations are on the boxes and not vials so nurse was unaware.  Call to local authority, told to complete VAERS and call manufacturer. If not viable: follow CDC guidelines which is to notify client and re-vaccinate in 8 weeks.  Pfizer requested data logger temps and calibration certificate as well as event details. Per Pfizer, we are within the 75 days of stability assessment.
within 2 days of initial Pfizer injection developed headache, fatigue, fever up to 100.7, neck ache, diarrhea up to 30 times a day, and severe abdominal cramping  pain (pain lasted 2 days). Patient has lost 8 pounds. Patient examined on day 6 of symptoms and still having intermittent low grade fever and diarrhea up to 5 times a day,
pt recvd vax; same day devel a swollen, tender & red inject site; tenderness & redness descended down the arm to the elbow by 14may94;
Sharp pain under left elbow, second vaccine; Arm hurt, second vaccine; Lethargic, second vaccine; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 60-years-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported, Expiry date was not reported) via an unspecified route of administration, administered in Arm Left on 16Apr2021 (at the age of 60 years old) as DOSE 2, SINGLE for covid-19 immunisation. Previously the patient has received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported, Expiry date was not reported) via an unspecified route of administration, administered in Arm Left on 25Mar2021 as DOSE 1, SINGLE for covid-19 immunisation which leads to Arm hurt, back of left arm and Lethargic. The patient medical history and concomitant medications were not reported. Caller states his left arm, where he got the shot, on the second day hurt (On 16Apr2021). Caller mentions that he had pain in his arm after the first vaccine, but that was to be expected. Caller also states he was lethargic after both vaccines. Caller states, under his left elbow, there is a sharp pain for 5 days, it is not killing him, but it is persistent, still present, and not going away (on an unspecified date) Caller states that everyone told him that their arm is uncomfortable, and they feel off for a couple of days, after the vaccine. Caller states, everyone he knows, his age or older, said the same thing. Caller states he had the arm pain, but two days later, the left elbow pain gave him pause and concern. Also, Caller states he did not feel like himself for a day or two. The outcome for the event Arm hurt, second vaccine was recovered and for the event Lethargic, second vaccine, Sharp pain under left elbow, second vaccine was unknown.  No follow-up attempts are possible, information about lot/batch number cannot be obtained.
Fever (99.6F, my baseline is 97.6F) developed wround 3pm 1/7/2021 - joint pain 6/10 without meds (begane around 11pm and worsened overnight.)  - body aches developed by morning  - fatigue (all say 1/7/2021, 2 hour nap, 8 hours of sleep at night, still fatigue. Worked 1/2 day)  Discontinued meloxicam to alternate between acetaminophen and ibuprofen. Fever will decrease. Joint pain becomes 4/10
Patient received 0.5 ml of COVID Moderna 6 mo-5 yr vaccine instead of 0.25 ml
In on 10/1/10 for 4 yr. well child check up and immunization. Back in on 10/4/10. Per MD, right leg 1.5" X 1.75" area of redness and tenderness, seems to be clearing, central warm but not hot. Left leg mostly resolved, 1 X 3/4" area pink, not warm. Suspect local reaction to immunizations.
This spontaneous report as received from a healthcare worker refers to multiple unspecified patients of unknown age and gender. Information regarding relevant medical history and concurrent condition were not reported. On multiple unspecified dates the patient was vaccinated with improperly stored M-M-R II (lot # L012480 with expiration date 10-APR-2017, lot # L010488 with expiration date 26-MAR-2017, dose and route not reported). No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
This spontaneous case reported by a consumer, describes the occurrence of bedridden (he has been in bed for 12 days), gait disturbance (he can't walk), muscle spasms (cramps), pain in extremity (pain in the legs) and pyrexia (fever) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. The occurrence of additional events detailed below. The patient's past medical history included stroke (5 years ago). Concurrent medical conditions included diabetes, high blood pressure and hepatitis. On Mar 18, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Mar 18, 2021, patient experienced bedridden (he has been in bed for 12 days), gait disturbance (he can't walk), muscle spasms (cramps), pain in extremity (pain in the legs), pyrexia (fever) and sleep disorder (sleeping problems). At the time of the report, bedridden (he has been in bed for 12 days), gait disturbance (he can't walk), muscle spasms (cramps), pain in extremity (pain in the legs), pyrexia (fever) and sleep disorder (sleeping problems) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. No concomitant medication or treatment information reported.
Adominal pain middle of chest below sternum, shortness of breath, twitching right eye, became fatigued
Covid arm ( red rash / welt) Dry cough Chills Fever Congestion  Headache
This case was reported by a physician via call center representative and described the occurrence of unable to walk in a adolescent female patient who received BEXSERO (batch number 166701, expiry date May 2018). Concomitant products included BEXSERO. On an unknown date, the patient received the 2nd dose of BEXSERO. On an unknown date, less than a day after receiving BEXSERO, the patient experienced unable to walk (serious criteria GSK medically significant), chills, tremor, dizziness, pain, headache, weakness generalized and anemia. On an unknown date, the outcome of the unable to walk, chills, tremor, dizziness, pain, headache, weakness generalized and anemia were recovered/resolved. It was unknown if the reporter considered the unable to walk, chills, tremor, dizziness, pain, headache, weakness generalized and anemia to be related to BEXSERO. Additional details were provided as follows: In April 2017, the patient received the 1st dose of BEXSERO one month before the reporting date. In 2017, within 2 hours after receiving 2nd dose of BEXSERO, the patient had chills, shaking, dizziness, pain, headaches, generalized weakness and was unable to walk. The patient was taken to the emergency room (ER) where blood was drawn which revealed that the patient was anemic. In 2017, all symptoms resolved within 30 minutes to an hour after initiating. No further information was reported regarding the event.
Blurry vision five minutes after receiving injection of HPV9 and influenza vaccinations.
rash devel for 7 days; no fever; less than 50 bumps/pox
No adverse reaction; Moderna 1st dose was the incorrect dosing at 0.25 mL vs 0.5 mL; This spontaneous case was reported by a nurse and describes the occurrence of UNDERDOSE (Moderna 1st dose was the incorrect dosing at 0.25 mL vs 0.5 mL) and NO ADVERSE EVENT (No adverse reaction) in a 9-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AR4504B) for COVID-19 prophylaxis.     Patient had no known drug allergies. It was unknown that the patient ever been diagnosed with or tested positive for COVID-19. The patient did not have acute illnesses at the time of vaccination and up to one month before or any chronic or long-standing health conditions.     On 13-Oct-2022 at 12:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 13-Oct-2022 at 12:00 PM, the patient experienced UNDERDOSE (Moderna 1st dose was the incorrect dosing at 0.25 mL vs 0.5 mL). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse reaction). At the time of the report, UNDERDOSE (Moderna 1st dose was the incorrect dosing at 0.25 mL vs 0.5 mL) and NO ADVERSE EVENT (No adverse reaction) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse reaction) to be not related. No further causality assessment was provided for UNDERDOSE (Moderna 1st dose was the incorrect dosing at 0.25 mL vs 0.5 mL).    No prescriptions, over-the-counter medications, dietary supplements, or herbal remedies being taken at time of vaccination or at the time of the adverse event were reported.   It was reported that upon filed the report it was identified during chart audit the patient was administered with Moderna 1st dose was the incorrect dosing at 0.25 mL instead of 0.5 mL.   Treatment medication was not provided by the reporter.   This case was linked to MOD-2022-676101 (Patient Link).
Flu-like. Chills, body ache, fever & headache.  Next day, diarrhea .
The vaccine expiration date was identified to expire on June 22, 2021, but the manufacturer expiration date was February 25, 2021. Based on the information learned, County Health took the following steps: - Covid-19 Response Unit Pharmacists contacted Moderna for guidance and based on Moderna data, the Moderna     Medical Information team provided the following information:  - The vaccine administered on March 4, 2021 through March 10, 2021 from lot number 025J20-2A maintained the     activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. -  A county medical director was contacted and based on this information from Moderna, no re-vaccination is needed.
Shot was very painful; Arm very sore; Couldnt move it; This case was reported by a consumer via interactive digital media and described the occurrence of injection site pain in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of injection site pain (also experienced sore arm after receiving 1st dose on an unknown date, refer case US2021AMR064333).   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, immediately after receiving Shingles vaccine, the patient experienced injection site pain, pain in arm and mobility decreased. Rechallenge with Shingles vaccine was positive. On an unknown date, the outcome of the injection site pain, pain in arm and mobility decreased were unknown.   It was unknown if the reporter considered the injection site pain, pain in arm and mobility decreased to be related to Shingles vaccine.  Additional details were reported as follows: The case was reported by the patient herself/himself. The age group was not reported but was selected as an adult as per vaccine indication. The age at vaccination was not reported. The patient received 2nd dose of Shingles vaccine and stated shot was very painful and made his/her arm very sore to where he/she could not move it. The follow-up would not possible as no contact details were available.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR064333:same report, same patient, different dose (2nd dose)
Within hours post vax, the pt developed a rash on her chest which was diagnosed as psoriasis. As of 07/21/2000, the outcome of the event is ongoing.
tested positive for Covid-19; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (tested positive for Covid-19) in a  patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 12-Oct-2022, the patient experienced COVID-19 (tested positive for Covid-19). At the time of the report, COVID-19 (tested positive for Covid-19) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Oct-2022, SARS-CoV-2 test: (Positive) Positive. In October 2022, SARS-CoV-2 test: (Negative) Negative.         No concomitant medications were reported. Patient received Moderna bivalent booster dose on 10-Oct-2022 and on 12-Oct-2022 tested positive for Covid-19.  Currently Covid- negative but would like to ask as they had the virus and the vaccine almost at the same time, are they protected from getting Covid, for at least 6 months. No treatment information was reported.   Reporter did not allow further contact